From: The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis
Current use of non-thiazides (DDDs/1000 inhabitants/day)*
Potential decrease (DDDs/1000 inhabitants/day)â€
Canada
92.7
2.8 (3%)
France
98.9
17.2 (17%)
Germany
107.7
13.5 (13%)
Norway
20.3 (22%)
UK
70.8
15.4 (22%)
US
127.7
8.4 (7%)